verisign inc. - VRSN
VRSN
Close Chg Chg %
199.96 1.52 0.76%
Pre-Market
201.48
+1.52 (0.76%)
Volume: 219.19K
Last Updated:
Dec 24, 2024, 1:00 PM EDT
Company Overview: verisign inc. - VRSN
VRSN Key Data
| Open $199.54 | Day Range 199.54 - 201.67 |
| 52 Week Range 167.05 - 208.04 | Market Cap $19.36B |
| Shares Outstanding 96.10M | Public Float 95.12M |
| Beta 0.92 | Rev. Per Employee N/A |
| P/E Ratio 23.44 | EPS $8.60 |
| Yield 0.00% | Dividend $2.75 |
| EX-DIVIDEND DATE May 5, 2011 | SHORT INTEREST N/A |
| AVERAGE VOLUME 677.42K |
VRSN Performance
| 1 Week | 1.33% | ||
| 1 Month | 7.64% | ||
| 3 Months | 5.69% | ||
| 1 Year | -2.18% | ||
| 5 Years | 3.83% |
VRSN Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
6
Full Ratings ➔
About verisign inc. - VRSN
VeriSign, Inc. engages in the provision of critical Internet infrastructure and domain name registry services. It helps enable the security, stability, and resiliency of the Domain Name System and the Internet by providing Root Zone Maintainer services. The company was founded by D. James Bidzos on April 12, 1995 and is headquartered in Reston, VA.
VRSN At a Glance
VeriSign, Inc.
12061 Bluemont Way
Reston, Virginia 20190
| Phone | 1-703-948-3200 | Revenue | 1.49B | |
| Industry | Internet Software/Services | Net Income | 817.60M | |
| Sector | Technology Services | 2023 Sales Growth | 4.786% | |
| Fiscal Year-end | 12 / 2024 | Employees | 908 | |
| View SEC Filings |
VRSN Valuation
| P/E Current | 23.44 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 26.073 |
| Price to Sales Ratio | 14.277 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 24.967 |
| Enterprise Value to EBITDA | 21.239 |
| Enterprise Value to Sales | 14.86 |
| Total Debt to Enterprise Value | 0.081 |
VRSN Efficiency
| Revenue/Employee | 1,644,383.26 |
| Income Per Employee | 900,440.529 |
| Receivables Turnover | 109.787 |
| Total Asset Turnover | 0.858 |
VRSN Liquidity
| Current Ratio | 0.832 |
| Quick Ratio | 0.832 |
| Cash Ratio | 0.779 |
VRSN Profitability
| Gross Margin | 86.786 |
| Operating Margin | 67.015 |
| Pretax Margin | 65.401 |
| Net Margin | 54.759 |
| Return on Assets | 46.956 |
| Return on Equity | N/A |
| Return on Total Capital | 377.644 |
| Return on Invested Capital | 372.738 |
VRSN Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 830.254 |
| Total Debt to Total Assets | 102.773 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 827.898 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Verisign Inc. - VRSN
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.27B | 1.33B | 1.42B | 1.49B | |
Sales Growth
| +2.71% | +4.94% | +7.33% | +4.79% | |
Cost of Goods Sold (COGS) incl D&A
| 180.18M | 191.93M | 200.70M | 197.30M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 46.35M | 47.94M | 46.90M | 44.10M | |
Depreciation
| 46.35M | 47.94M | 46.90M | 44.10M | |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| -0.16% | +6.52% | +4.57% | -1.69% | |
Gross Income
| 1.08B | 1.14B | 1.22B | 1.30B | |
Gross Income Growth
| +3.20% | +4.68% | +7.80% | +5.85% | |
Gross Profit Margin
| +85.76% | +85.54% | +85.91% | +86.79% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 260.67M | 268.84M | 281.10M | 295.20M | |
Research & Development
| 74.67M | 80.53M | 85.70M | 91.00M | |
Other SG&A
| 186.00M | 188.31M | 195.40M | 204.20M | |
SGA Growth
| +6.37% | +3.13% | +4.56% | +5.02% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | 2.15M | (9.80M) | - |
EBIT after Unusual Expense
| 824.20M | 864.65M | 943.10M | 1.01B | |
Non Operating Income/Expense
| 16.19M | 820.00K | 12.40M | 41.40M | |
Non-Operating Interest Income
| 7.82M | 582.00K | 14.90M | 46.10M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 90.14M | 83.25M | 75.30M | 75.30M | |
Interest Expense Growth
| - | -0.52% | -7.64% | -9.55% | |
Gross Interest Expense
| 90.14M | 83.25M | 75.30M | 75.30M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 750.24M | 782.22M | 880.20M | 976.50M | |
Pretax Income Growth
| -1.12% | +4.26% | +12.53% | +10.94% | |
Pretax Margin
| +59.31% | +58.92% | +61.77% | +65.40% | |
Income Tax
| (64.64M) | (2.61M) | 206.40M | 158.90M | |
Income Tax - Current - Domestic
| (113.41M) | 129.61M | 186.80M | 187.10M | |
Income Tax - Current - Foreign
| 29.15M | 29.83M | 26.30M | 24.40M | |
Income Tax - Deferred - Domestic
| 21.74M | 3.71M | (22.80M) | (14.40M) | |
Income Tax - Deferred - Foreign
| (2.12M) | (165.76M) | 16.10M | (38.20M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 814.89M | 784.83M | 673.80M | 817.60M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 814.89M | 784.83M | 673.80M | 817.60M | |
Net Income Growth
| +33.09% | -3.69% | -14.15% | +21.34% | |
Net Margin Growth
| +64.42% | +59.12% | +47.29% | +54.76% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 814.89M | 784.83M | 673.80M | 817.60M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 814.89M | 784.83M | 673.80M | 817.60M | |
EPS (Basic)
| 7.0824 | 7.0065 | 6.2447 | 7.9072 | |
EPS (Basic) Growth
| +37.08% | -1.07% | -10.87% | +26.62% | |
Basic Shares Outstanding
| 115.06M | 112.02M | 107.90M | 103.40M | |
EPS (Diluted)
| 7.0677 | 6.997 | 6.2389 | 7.8995 | |
EPS (Diluted) Growth
| +37.32% | -1.00% | -10.83% | +26.62% | |
Diluted Shares Outstanding
| 115.30M | 112.17M | 108.00M | 103.50M | |
EBITDA
| 870.55M | 914.74M | 990.00M | 1.04B | |
EBITDA Growth
| +2.12% | +5.08% | +8.23% | +5.53% | |
EBITDA Margin
| +68.82% | +68.90% | +69.48% | +69.97% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 205.00 | |
| Number of Ratings | 6 | Current Quarters Estimate | 1.999 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 7.995 | |
| Last Quarter’s Earnings | 2.07 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 7.90 | Next Fiscal Year Estimate | 8.546 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 2 | 2 | 2 | 2 |
| Mean Estimate | 2.00 | 2.06 | 7.99 | 8.55 |
| High Estimates | 2.01 | 2.08 | 8.00 | 8.55 |
| Low Estimate | 1.99 | 2.05 | 7.99 | 8.54 |
| Coefficient of Variance | 0.80 | 1.11 | 0.09 | 0.10 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 1 |
| OVERWEIGHT | 2 | 1 | 2 |
| HOLD | 3 | 4 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Hold | Overweight |
SEC Filings for Verisign Inc. - VRSN
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Verisign Inc. - VRSN
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jul 25, 2024 | Courtney D. Armstrong Director | 5,154 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 25, 2024 | Roger H. Moore Director | 44,802 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 25, 2024 | Jamie S. Gorelick Director | 21,315 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 25, 2024 | Kathleen A. Cote Director | 30,346 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 25, 2024 | Timothy Tomlinson Director | 16,408 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 25, 2024 | Thomas Fearn Frist Director | 16,218 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 25, 2024 | Yehuda Ari Buchalter Director | 4,335 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 17, 2024 | John D. Calys SVP, Cont., Chief Acct Officer | 22,223 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.9 per share | 3,931,248.70 |
| Jul 17, 2024 | Danny McPherson EVP - Engineering & CSO | 29,155 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.9 per share | 5,157,519.50 |
| May 14, 2024 | Yehuda Ari Buchalter Director | 2,927 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $170.02 per share | 497,648.54 |
| Mar 14, 2024 | Thomas C. Indelicarto EVP, Gen Counsel & Secretary | 43,183 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $192.37 per share | 8,307,113.71 |
| Mar 5, 2024 | Danny McPherson EVP- Engineering, Ops. & CSO | 30,895 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $194.15 per share | 5,998,264.25 |
| Feb 23, 2024 | Todd B. Strubbe President & COO | 111,551 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $193.69 per share | 21,606,313.19 |
| Feb 23, 2024 | Todd B. Strubbe President & COO | 112,942 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $193.12 per share | 21,811,359.04 |
| Feb 15, 2024 | George E. Kilguss EVP and CFO | 114,079 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 15, 2024 | D. James Bidzos Exec. Chairman & CEO; Director | 524,269 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 15, 2024 | Thomas C. Indelicarto EVP, Gen Counsel & Secretary | 43,143 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $195.33 per share | 8,427,122.19 |